{
  "docId": "019de075-2875-74d4-8194-84b6aaf5cb83",
  "docSlug": "17078b9c485724b1d98591e3cd98aa3e",
  "documentTitle": "Kymera | Investor Presentation Deck | 60 slides",
  "authorId": "kymera",
  "authorName": "Kymera",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 60,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "solution",
  "function": "present_solution",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": "TPD = Targeted Protein Degradation. UD = Undrugged. ID = Inadequately Drugged. PK = Pharmacokinetics. PD = Pharmacodynamics. SMI = Small Molecule Inhibitor.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-2875-74d4-8194-84b6aaf5cb83/4",
  "deckHref": "/decks/019de075-2875-74d4-8194-84b6aaf5cb83",
  "deckJsonHref": "/decks/019de075-2875-74d4-8194-84b6aaf5cb83.json",
  "deckAnchorHref": "/decks/019de075-2875-74d4-8194-84b6aaf5cb83#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.52,
        "y": 0.0075
      },
      "kind": "chart",
      "text": "Percent Change from Baseline",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "89b75fdd-01a2-4212-9e06-9e18804686be",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.52,
        "y": 0.0045
      },
      "kind": "chart",
      "text": "Percent Change from Baseline IRAK4",
      "attrs": null,
      "subkind": "scatter",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "935d4a46-2852-405c-9f63-32a10ebef7ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.28,
        "y": 0.0045
      },
      "kind": "image",
      "text": "Molecular structures",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "716b1f7b-6a90-4c58-bd64-c0e878e06cb3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.2,
        "x": 0.05,
        "y": 0.0045
      },
      "kind": "image",
      "text": "Protein structures",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b69a2b64-5ee1-4334-a3b4-0c9532572a83",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.9,
        "x": 0.05,
        "y": 0.0015
      },
      "kind": "list",
      "text": "TARGET SELECTION; PLATFORM; CLINICAL TRANSLATION; TPD \"FIRSTS\"",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "749f5c17-a75a-47b1-b63c-21536ddb3b89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.22,
        "x": 0.75,
        "y": 0.004200000000000001
      },
      "kind": "list",
      "text": "FIRST randomized, placebo-controlled trial in healthy volunteers with KT-474 (IRAK4); FIRST heterobifunctional degrader with clinical activity...; FIRST demonstration of biological and clinical differentiation...; FIRST heterobifunctional degrader against an undrugged transcription factor in clinic with KT-333 (STAT3)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ed825b6c-41c7-433f-8340-c5c06bbc40af",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.05,
        "y": 0.0034
      },
      "kind": "paragraph",
      "text": "Undrugged (UD) or inadequately drugged (ID) targets",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f6f8b1a4-e7e4-45bf-adc3-0fcd4e1b390b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.56,
        "x": 0.22,
        "y": 0.04
      },
      "kind": "title",
      "text": "Kymera's Differentiated Approach to TPD",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "551ac3d3-9f97-4506-8f5c-e64756d73b02",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}